Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$723
|
$684B |
13.4x |
34.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$186
|
$393B |
6.8x |
15.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$154
|
$383B |
4.3x |
11.8x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 454
|
$315B |
6.8x |
13.8x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 262
|
$274B |
3.7x |
9.4x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 93
|
$244B |
4.5x |
11.0x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£104
|
$242B |
4.2x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$76
|
$217B |
3.4x |
7.9x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$284
|
$201B |
5.9x |
10.5x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$404
|
$181B |
4.2x |
16.7x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$177B |
2.8x |
7.3x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$111
|
$155B |
5.4x |
12.6x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$190
|
$151B |
6.3x |
19.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€93
|
$142B |
2.8x |
9.5x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$48
|
$137B |
2.9x |
12.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$447
|
$110B |
9.7x |
40.4x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$97.5B |
2.3x |
6.6x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 248
|
$87.5B |
5.7x |
16.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$167
|
$79.4B |
8.5x |
19.8x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7600
|
$79.3B |
9.7x |
19.6x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4252
|
$73.8B |
2.3x |
9.0x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$64.3B |
2.7x |
9.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€25
|
$63.9B |
1.2x |
5.8x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$60.8B |
4.0x |
16.0x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$605
|
$59.7B |
4.3x |
11.8x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1026000
|
$53.2B |
14.6x |
35.6x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 561
|
$52.7B |
6.3x |
22.0x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 54
|
$46.2B |
11.4x |
44.8x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3894
|
$45.5B |
3.5x |
17.0x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1700
|
$44.9B |
7.2x |
25.3x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$516
|
$42.4B |
10.6x |
31.3x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€43
|
$39.4B |
1.6x |
9.7x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$141
|
$37.0B |
2.4x |
9.9x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$293
|
$36.9B |
14.7x |
223.2x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$35.7B |
2.1x |
7.2x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€155
|
$34.5B |
4.8x |
17.9x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$113
|
$34.2B |
5.1x |
17.6x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 105
|
$32.2B |
6.8x |
29.3x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€509
|
$31.6B |
10.8x |
89.2x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$247
|
$26.8B |
2.0x |
11.8x |
BeiGene
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 157
|
$26.6B |
6.2x |
-185.3x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1173
|
$26.4B |
6.8x |
21.2x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 158700
|
$26.0B |
9.2x |
30.7x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$172
|
$25.6B |
2.5x |
12.6x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 40
|
$24.5B |
2.2x |
11.0x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.8B |
1.7x |
5.4x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6881
|
$23.7B |
1.5x |
6.4x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€193
|
$23.5B |
7.3x |
25.3x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$23.5B |
2.5x |
7.3x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 65
|
$23.3B |
4.1x |
11.3x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$324
|
$23.2B |
10.3x |
46.3x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$355
|
$22.3B |
7.4x |
20.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 6
|
$22.0B |
2.2x |
6.4x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1414
|
$21.6B |
1.6x |
8.5x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$158
|
$20.8B |
11.4x |
-85.8x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6632
|
$20.2B |
17.9x |
55.8x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$19.6B |
6.8x |
7.3x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$19.1B |
N/A |
-73.4x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 204
|
$17.1B |
11.0x |
33.3x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.8B |
2.0x |
8.2x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 26
|
$16.5B |
9.4x |
25.2x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 286
|
$15.8B |
26.3x |
52.8x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€117
|
$15.5B |
3.4x |
14.3x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€57
|
$14.7B |
1.8x |
8.3x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$84
|
$14.7B |
3.4x |
12.8x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$14.3B |
5.1x |
13.9x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$131
|
$13.4B |
1.7x |
8.0x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$92
|
$13.0B |
4.7x |
15.1x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3161
|
$12.8B |
9.3x |
28.6x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 334500
|
$12.7B |
117.4x |
280.5x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1477
|
$12.7B |
3.9x |
15.2x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2466
|
$12.6B |
8.5x |
33.8x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$58
|
$12.6B |
4.3x |
34.0x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 26
|
$12.6B |
4.6x |
13.4x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$12.5B |
30.9x |
-13.8x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 62
|
$12.3B |
8.6x |
280.9x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.1B |
2.1x |
15.4x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1248
|
$12.0B |
3.1x |
11.6x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 294
|
$11.7B |
4.2x |
11.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$11.7B |
4.7x |
18.7x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 69
|
$11.7B |
N/A |
N/A |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$320
|
$11.3B |
3.7x |
7.1x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 22
|
$10.9B |
1.9x |
11.3x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.9B |
1.7x |
5.6x |
Sonic Healthcare
|
Australia |
Laboratory Services,
Medical Imaging & Diagnostics
|
AUD 26
|
$10.9B |
1.8x |
9.7x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.8B |
4.8x |
14.5x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1969
|
$10.6B |
3.9x |
16.6x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$14
|
$10.6B |
2.4x |
12.0x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$59
|
$10.6B |
3.6x |
14.4x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$10.4B |
2.3x |
18.7x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 43
|
$10.4B |
1.7x |
13.7x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 925
|
$10.3B |
3.7x |
12.7x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$45
|
$10.2B |
5.1x |
13.8x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.0B |
2.5x |
10.1x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€140
|
$9.9B |
N/A |
N/A |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$139
|
$9.9B |
1.3x |
8.0x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1379
|
$9.7B |
2.9x |
8.3x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2388
|
$9.7B |
3.2x |
7.8x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$741
|
$9.6B |
N/A |
N/A |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$108
|
$9.5B |
2.3x |
6.6x |